Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

Published:2015-09-22 Issue:9 Volume:2015 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Cheyne Leanne¹,Irvin-Sellers Melanie J²,White John³

Affiliation:

1. Bradford Teaching Hospitals NHS Foundation Trust; Respiratory Medicine; Duckworth Lane Bradford UK

2. St Peter's Hospital; Respiratory Medicine; Chertsey Surrey UK

3. York Teaching Hospital; Respiratory Medicine; Wigginton Rd York North Yorks UK YO31 8HE

Publisher

Wiley

Subject

Pharmacology (medical)

Reference39 articles.

1. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease;Oostenbrink;European Respiratory Journal,2004

2. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease;Noord;Thorax,2000

3. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium;Vincken;European Respiratory Journal,2002

4. 205.251 SPIRIVA ® - Pulmonary Disease, Chronic Obstructive (Clinical trial 205.251) http://trials.boehringer-ingelheim.com/trial_results/clinical_trials_overview/205/205_251.html

5. 205.252 SPIRIVA ® - Pulmonary Disease, Chronic Obstructive http://trials.boehringer-ingelheim.com/trial_results/clinical_trials_overview/205/205_252.html

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease;Archivos de Bronconeumología;2024-04

2. Signal Mining and Analysis of Cardiovascular Adverse Events of Tiotropium Bromide Based on the FAERS Database;Advances in Clinical Medicine;2024

3. Tiotropium bromide in the treatment of chronic obstructive pulmonary disease;PULMONOLOGIYA;2023-12-13

4. Patterns and Trends in the Use of Medications for COPD Control in a Cohort of 9476 Colombian Patients, 2017–2019;International Journal of Chronic Obstructive Pulmonary Disease;2023-07

5. Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System;Biomolecules;2023-03-05